The Advanced Imaging Program (Program 5) is a highly integrated and collaborative program. Given the crucial impact of imaging in cancer diagnosis and treatment, the Program plays a key role in research at the UCCRC. It consists of 24 members from two Departments, with $5,766,868 in peer-reviewed funding, $2,210,919 of which is from NCI. Of 229 peer-reviewed publications during the current project period, 65 (28%) were intraprogrammatic collaborations, and 34 (15%) represented interprogrammatic collaborations. Imaging is used in virtually every cancer patient, in many animal models of cancer, and in a large number of in vitro cancer-related experiments. Thus, imaging research is fundamental to advanced cancer research. The Advanced Imaging Program is focused on enhancing the collaboration among imaging scientists involved in cancer research at the University of Chicago. Recent advances in image analysis methods, as well as in computer processing speeds, have led to, and facilitated, an expanded interest in research in quantitative image analysis. Image analysis investigations now underway within the UCCRC include work with x-ray, ultrasound, magnetic resonance, and radionuclide images, and molecular and physiological modeling. Imaging system research within the UCCRC continues to expand with the establishment of more animal imaging facilities for both basic imaging developments and for use in cancer research that uses animal models. The overall objective of the UCCRC Advanced Imaging Program is to integrate and focus the work of investigators with established research programs, to investigate new methods for the production and analysis of images for prevention, diagnosis, and treatment of cancer, and to translate developed methods from the laboratory to the clinical arena. The research objectives are to: ? Investigate new methods for computerized image analysis to help in the early diagnosis of cancer; ? Investigate new methods of image reconstruction for use in CT (computed tomography), SPECT (single photon emission computed tomography), and PET imaging; ? Develop new methods of image acquisition such as MRIS (magnetic resonance imaging and spectroscopy) and EPR (electron paramagnetic resonance imaging); ? Identify imaging methods for oncology practice and for the evaluation of response to target-based cancer drugs;and ? Investigate methods for the evaluation of imaging systems, especially as they apply to computeraided diagnosis and new imaging instrumentation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-36
Application #
8244540
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-04-01
Budget End
2012-03-31
Support Year
36
Fiscal Year
2011
Total Cost
$41,592
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications